Provided by Tiger Trade Technology Pte. Ltd.

Chaince Digital Holdings Inc.

2.99
-0.1250-4.02%
Volume:40.69K
Turnover:121.84K
Market Cap:328.35M
PE:-45.83
High:3.12
Open:3.11
Low:2.91
Close:3.11
52wk High:36.77
52wk Low:2.10
Shares:110.00M
Float Shares:87.22M
Volume Ratio:1.40
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0651
EPS(LYR):-0.0772
ROE:-7.73%
ROA:-6.37%
PB:7.02
PE(LYR):-38.67

Loading ...

Cellectis granted RMAT designation for lasmecabtagene timgedleucel from FDA

TIPRANKS
·
Jun 10

Top News Today: Stocks Mixed as Semiconductor Cos Rebound

Dow Jones
·
Jun 09

Top News Today/Canada: Kneat.com to be Acquired by Thoma Bravo

Dow Jones
·
Jun 09

Chaince Digital Announces Board Resignation and Leadership Change

TIPRANKS
·
Jun 06

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

GlobeNewswire
·
Jun 05

CD Projekt upgraded to Neutral from Underperform at Oddo BHF

TIPRANKS
·
Jun 04

Chaince Digital CSO, Director Wilfred Daye sells USD 35,200 in common shares

Reuters
·
Jun 04

CD Projekt Reports Q1 Net Profit of 106 Million PLN as The Witcher 3 Sales Exceed 65 Million

Deep News
·
May 30

CD Projekt Stock (OTGLY) Drops Despite a Surprise Witcher 3 DLC Reveal

TIPRANKS
·
May 28

CD Projekt announces new ‘Witcher 3’ expansion ‘Songs of the Past,’ out 2027

TIPRANKS
·
May 28

Barclays Sticks to Its Sell Rating for CD Projekt SA (OTGLF)

TIPRANKS
·
May 27

Chaince Digital Holdings Falls To US$7.39, But Insiders Sold At Lower Price

Simply Wall St.
·
May 24

Chaince Digital CSO Wilfred ZhongKei Daye sells $77,267.76 in common shares

Reuters
·
May 22

Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease

prnewswire
·
May 18

CD Projekt SA (OTGLF) Receives a Sell from Goldman Sachs

TIPRANKS
·
May 18

I have $310,000 in cash from a maturing CD. Where should I put it next?

Dow Jones
·
May 17

Chaince Q1 FY26 net loss widens 3.92% to $1.35 million; revenue rises to $507,546

Reuters
·
May 15

Press Release: Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
May 14

I have $310,000 in cash from a maturing CD. Where should I put it next?

Dow Jones
·
May 13

I have $310,000 in cash from a maturing CD. Where should I put it next?

Dow Jones
·
May 11